» Authors » Paolo Paoletti

Paolo Paoletti

Explore the profile of Paolo Paoletti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 2441
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Mouro J, Pinto R, Paoletti P, Tiribilli B
Sensors (Basel) . 2020 Dec; 21(1). PMID: 33375431
A microcantilever is a suspended micro-scale beam structure supported at one end which can bend and/or vibrate when subjected to a load. Microcantilevers are one of the most fundamental miniaturized...
12.
Chang Z, Paoletti P, Hansen M, Beck H, Chen P, Rasmussen L, et al.
Scanning . 2018 Dec; 2018:6340425. PMID: 30524642
Using the atomic force microscopy- (AFM-) PeakForce quantitative nanomechanical mapping (QNM) technique, we have previously shown that the adventitia of the human internal mammary artery (IMA), tested under dehydrated conditions,...
13.
Chang Z, Paoletti P, Barrett S, Chim Y, Caamano-Gutierrez E, Hansen M, et al.
Acta Biomater . 2018 Apr; 73:437-448. PMID: 29684625
Statement Of Significance: Arterial stiffening occurs as part of the natural aging process and is strongly linked to cardiovascular risk. Although arterial stiffening is routinely measured in vivo, little is...
14.
Lin N, Dieras V, Paul D, Lossignol D, Christodoulou C, Stemmler H, et al.
Clin Cancer Res . 2009 Feb; 15(4):1452-9. PMID: 19228746
Purpose: Brain metastases develop in one third of patients with advanced HER2+ breast cancer. Effective therapy for patients with central nervous system (CNS) progression after cranial radiation is extremely limited...
15.
Cosci F, Corlando A, Fornai E, Pistelli F, Paoletti P, Carrozzi L
Addict Behav . 2008 Sep; 34(1):28-35. PMID: 18804918
Aim: Nicotine replacement therapy (NRT) is an effective treatment for smokers who want to quit, however, the rates of successful quitting can be improved even more. In this context, nicotine...
16.
Paoletti P
J Clin Oncol . 2008 Aug; 26(22):3815-6. PMID: 18669476
No abstract available.
17.
Cameron D, Casey M, Press M, Lindquist D, Pienkowski T, Romieu C, et al.
Breast Cancer Res Treat . 2008 Jan; 112(3):533-43. PMID: 18188694
Purpose: Lapatinib is a small molecule, dual tyrosine kinase inhibitor of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor type 2 (HER2). Initial results of a phase...
18.
Hanauske A, Eismann U, Oberschmidt O, Pospisil H, Hoffmann S, Hanauske-Abel H, et al.
Invest New Drugs . 2007 May; 25(5):417-23. PMID: 17534577
Aim Of The Study: mRNA expression of genes involved in the mechanism of action of pemetrexed was correlated with in vitro chemosensitivity of freshly explanted human tumor specimens. Experimental Design:...
19.
Hanna N, Shepherd F, Fossella F, Pereira J, de Marinis F, von Pawel J, et al.
J Clin Oncol . 2004 May; 22(9):1589-97. PMID: 15117980
Purpose: To compare the efficacy and toxicity of pemetrexed versus docetaxel in patients with advanced non-small-cell lung cancer (NSCLC) previously treated with chemotherapy. Patients And Methods: Eligible patients had a...
20.
Vogelzang N, Rusthoven J, Symanowski J, Denham C, Kaukel E, Ruffie P, et al.
J Clin Oncol . 2003 Jul; 21(14):2636-44. PMID: 12860938
Purpose: Patients with malignant pleural mesothelioma, a rapidly progressing malignancy with a median survival time of 6 to 9 months, have previously responded poorly to chemotherapy. We conducted a phase...